Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

STORM-PE: A Prospective, Multicenter, Randomized Controlled Trial Evaluating Anticoagulation Alone vs Anticoagulation Plus Mechanical Aspiration With the Indigo® Aspiration System for the Treatment of Intermediate High Risk Acute Pulmonary Embolism

NCT05684796 is registered in ClinicalTrials.gov with Penumbra Inc. as lead sponsor.

NCT NCT05684796
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05684796 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
STORM-PE: A Prospective, Multicenter, Randomized Controlled Trial Evaluating Anticoagulation Alone vs Anticoagulation Plus Mechanical Aspiration With the Indigo® Aspiration System for the Treatment of Intermediate High Risk Acute Pulmonary Embolism
Lead sponsor
Penumbra Inc.
Phase
Not applicable
Overall status
Completed
Start date
November 27, 2023
Completion date
September 9, 2025
Enrollment
100 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary embolism acute